Ilan Hadar - Net Worth and Insider Trading
Ilan Hadar Net Worth
The estimated net worth of Ilan Hadar is at least $266,944 dollars as of 2026-09-10. Ilan Hadar is the CFO & Country Manager of Foamix Pharmaceuticals Ltd and owns about 89,279 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $266,944. Details can be seen in Ilan Hadar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ilan Hadar has not made any transactions after 2019-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ilan Hadar
Ilan Hadar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ilan Hadar owns 3 companies in total, including VYNE Therapeutics Inc (VYNE) , Foamix Pharmaceuticals Ltd (FOMX) , and Silexion Therapeutics Corp (SLXN) .
Click here to see the complete history of Ilan Hadar’s form 4 insider trades.
Insider Ownership Summary of Ilan Hadar
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2020-03-09 | CFO and Country Manager |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | CFO & Country Manager |
| SLXN | Silexion Therapeutics Corp | 2024-08-15 | director & Chairman and CEO |
Ilan Hadar Latest Holdings Summary
Ilan Hadar currently owns a total of 1 stock. Ilan Hadar owns 89,279 shares of Foamix Pharmaceuticals Ltd (FOMX) as of September 10, 2019, with a value of $266,944.
Latest Holdings of Ilan Hadar
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd | 2019-09-10 | 89,279 | 2.99 | 266,944 |
Holding Weightings of Ilan Hadar
Ilan Hadar Form 4 Trading Tracker
According to the SEC Form 4 filings, Ilan Hadar has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 43,812 shares on September 10, 2019, which brought Ilan Hadar around $153,342.
Insider Trading History of Ilan Hadar
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ilan Hadar Trading Performance
Ilan Hadar Ownership Network
Ownership Network List of Ilan Hadar
Ownership Network Relation of Ilan Hadar
Ilan Hadar Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Ilan Hadar is the CFO and Country Manager of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include 10 percent owner Rtw Fund Group Gp, Llc , director & Chief Executive Officer Rebecca Frey , and Chief Development Officer Lori Payton .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Ilan Hadar Mailing Address
Above is the net worth, insider trading, and ownership report for Ilan Hadar. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ilan Hadar's mailing address is: Rehovot L3 76704.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
